Study on adherence to positive airway pressure treatment for patients with obstructive sleep apnea using real-world big data in a telemedicine management system

医学 阻塞性睡眠呼吸暂停 气道正压 远程医疗 持续气道正压 正压 睡眠(系统调用) 内科学 麻醉 医疗保健 计算机科学 经济增长 操作系统 经济
作者
Huijie Yi,Shaomei Shang,Yuan Zhang,Chi Zhang,Liyue Xu,Jingyu Wang,Xiaojun He,Xiaosong Dong,Fang Han
出处
期刊:Methods [Elsevier BV]
卷期号:204: 92-100 被引量:8
标识
DOI:10.1016/j.ymeth.2022.04.006
摘要

Obstructive Sleep Apnea (OSA) is a disorder that is characterized by obstructive apneas and hypopneas/respiratory effort-related arousals caused by upper airway collapse during sleep. Positive Airway Pressure (PAP) is the first-line treatment for moderate to severe OSA. However, the effectiveness of PAP therapies is contingent on treatment adherence. With the implementation of the wireless transmission for PAP treatment, it is possible to evaluate the objective adherence to PAP use. The purpose of this study is to assess the adherence to PAP therapy of Chinese OSA patients in a telemedicine management system which could fulfill automatic transmission of PAP treatment data. First, we use the telemedicine management system to extract PAP adherence information of OSA adult patients in one week, one month, three months, six months and 12 months. Second, we describe the general profile of PAP therapy adherence. Third, the latent class growth modeling and growth mixture modeling was conducted using Mplus 8.0 to identify the trajectories of adherence over time. Of all the 662 patients involved in our study, PAP adherence declined over time. After one year, the proportion of days compliant was 53.7%, the proportion of good compliance was 45.2%, the daily usage (all days) was 3.9 h/night, slightly lower than subjective adherence reported in the previous literatures. In addition, we identified three patterns of adherence over time: great users (39.9%; high mean value and level, negative slope, slow decline), good users (34.8%; moderate mean value and level, negative slope, rapid decline) and low users (25.3%; low mean value and level, negative slope, rapid decline). In brief, telemedicine management system provides a convenient platform for monitoring the treatment compliance of OSA patients powerfully and accurately. To improve the low PAP adherence in China, we should make good use of the PAP therapy telemedicine management platform to detect patients with poor adherence and provide timely intervention. Besides, our research provides a foundation for future studies to explore the determinants of observed trajectories of PAP adherence based on the telemedicine platforms.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小醒笑哈哈完成签到 ,获得积分10
刚刚
暮时完成签到 ,获得积分10
1秒前
yummm完成签到 ,获得积分10
2秒前
落寞白曼完成签到,获得积分0
2秒前
香太郎完成签到 ,获得积分10
2秒前
寂静沐风完成签到,获得积分10
3秒前
3秒前
PP发布了新的文献求助80
4秒前
mama完成签到,获得积分10
4秒前
空空完成签到,获得积分20
5秒前
科目三应助ercha采纳,获得10
6秒前
wq完成签到,获得积分10
6秒前
无辜秋珊发布了新的文献求助10
9秒前
10秒前
NexusExplorer应助buerger采纳,获得10
11秒前
Yjweei完成签到,获得积分10
12秒前
PP关闭了PP文献求助
12秒前
12秒前
14秒前
搜集达人应助957采纳,获得10
14秒前
李健应助Ycai采纳,获得10
15秒前
19秒前
充电宝应助奋斗靖仇采纳,获得10
20秒前
22秒前
22秒前
无辜秋珊完成签到,获得积分10
22秒前
SciGPT应助mk采纳,获得10
23秒前
ercha发布了新的文献求助10
23秒前
24秒前
一个one子发布了新的文献求助10
24秒前
地球发布了新的文献求助10
25秒前
XIZHENG_完成签到,获得积分10
25秒前
karry完成签到,获得积分10
26秒前
贪玩的成危完成签到,获得积分10
26秒前
lingua完成签到,获得积分10
26秒前
华仔应助Sunnig盈采纳,获得10
27秒前
高大荔枝完成签到,获得积分20
28秒前
丘比特应助DangJL采纳,获得10
28秒前
30秒前
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
A Research Agenda for Law, Finance and the Environment 800
Development Across Adulthood 800
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
A Time to Mourn, A Time to Dance: The Expression of Grief and Joy in Israelite Religion 700
The formation of Australian attitudes towards China, 1918-1941 640
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6446590
求助须知:如何正确求助?哪些是违规求助? 8259871
关于积分的说明 17596513
捐赠科研通 5507692
什么是DOI,文献DOI怎么找? 2902033
邀请新用户注册赠送积分活动 1879114
关于科研通互助平台的介绍 1719358